Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan.

Trials - 30 Jun 2020

Lo Serigne N, Smit Amelia K, Espinoza David, Cust Anne E

Abstract excerpt

BACKGROUND: The Melanoma Genomics Managing Your Risk Study is a randomised controlled trial that aims to evaluate the efficacy of providing information on personal genomic risk of melanoma in reducing ultraviolet radiation (UV) exposure, stratified by traditional risk group (low or high phenotypic risk) in the general population. The primary outcome is objectively measured total daily Standard Erythemal Doses at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Australia
Share to Cost-Benefit Analysis
Share to Data Interpretation, Statistical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Environmental Exposure

Share to Health Behavior

Share to Randomized Controlled Trials as Topic

Share to Skin Neoplasms

Share to Ultraviolet Rays

Source

Open in PubMed Open full text

Identifiers

PMID: 32605576
DOI: 10.1186/s13063-020-04351-w
PMCID: PMC7329549

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan.PMID 32605576Read ↗

The Melanoma Genomics Managing Your Risk Study randomised controlled trial: Statistical Analysis PlanSemantic proximity Read ↗

The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.Semantic proximity Read ↗

Recommendations for Primary Prevention of Skin MelanomaSemantic proximity Read ↗

A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.Semantic proximity Read ↗

Exploring the Potential Emotional and Behavioural Impact of Providing Personalised Genomic Risk Information to the Public: A Focus Group Study.Semantic proximity Read ↗

Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma.Semantic proximity Read ↗

Evaluating an approach for communicating integrated risk scores for melanoma.Semantic proximity Read ↗

GP attitudes to and expectations for providing personal genomic risk information to the public: a qualitative studySemantic proximity Read ↗

Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General PopulationSemantic proximity Read ↗

Can Patient-Led Surveillance Detect Subsequent New Primary or Recurrent Melanomas and Reduce the Need for Routinely Scheduled Follow Up? A Protocol for the MEL-SELF Randomised Controlled Trial.Semantic proximity Read ↗

Individual risk of cutaneous melanoma in New Zealand: developing a clinical prediction aid.Semantic proximity Read ↗

Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.